These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of ganciclovir resistance in CMV UL54 and UL97 gene regions in immunocompromised patients receiving gancyclovir treatment]. Delice S; Gökahmetoğlu S; Kaynar L; Karakükcü M Mikrobiyol Bul; 2015 Jul; 49(3):393-402. PubMed ID: 26313280 [TBL] [Abstract][Full Text] [Related]
6. [Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene]. Oyarzún MA; Bustos P; González M; Domínguez MI; Aguayo F; Nervi B; Ferres M Rev Med Chil; 2010 Apr; 138(4):421-7. PubMed ID: 20668789 [TBL] [Abstract][Full Text] [Related]
7. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene. Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247 [TBL] [Abstract][Full Text] [Related]
8. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection. Rose J; Emery VC; Kumar D; Asberg A; Hartmann A; Jardine AG; Bignamini AA; Humar A; Neumann AU PLoS Pathog; 2017 Apr; 13(4):e1006299. PubMed ID: 28406982 [TBL] [Abstract][Full Text] [Related]
9. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay. Eckle T; Jahn G; Hamprecht K J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754 [TBL] [Abstract][Full Text] [Related]
10. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients. Garrigue I; Moulinas R; Recordon-Pinson P; Delacour ML; Essig M; Kaminski H; Rerolle JP; Merville P; Fleury H; Alain S J Clin Virol; 2016 Jul; 80():74-81. PubMed ID: 27214758 [TBL] [Abstract][Full Text] [Related]
11. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child. Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411 [TBL] [Abstract][Full Text] [Related]
12. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient. García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746 [TBL] [Abstract][Full Text] [Related]
13. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report. Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289 [TBL] [Abstract][Full Text] [Related]
14. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan. Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621 [TBL] [Abstract][Full Text] [Related]
15. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. Gilbert C; Handfield J; Toma E; Lalonde R; Bergeron MG; Boivin G AIDS; 1998 Jan; 12(2):125-9. PubMed ID: 9468360 [TBL] [Abstract][Full Text] [Related]
16. Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies. Ruiz-Carrascoso G; Romero-Gómez MP; Plaza D; Mingorance J J Med Virol; 2013 Jul; 85(7):1250-7. PubMed ID: 23592041 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance. Recio V; González I; Tarragó D Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients. Tasoujlu M; Khalafkhany D; Makhdoomi K; Motazakker M Bratisl Lek Listy; 2022; 123(7):518-522. PubMed ID: 35907059 [TBL] [Abstract][Full Text] [Related]